Standardised guidance for the the investigatio... - CLL Support
Standardised guidance for the the investigation and management of CLL in Australia and NZ
You need to be a member of this community to see this post.
Read more about...
- Vaccination
- Genetic test
- Venetoclax
- Immunoglobulin
- Combination therapy
- BCG vaccine
- Chronic leukaemia
- Targeted therapy
- Shingrix
- Yellow fever vaccine
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
Managing the cardiovascular risk of Bruton's Tyrosine Kinase Inhibitors in chronic lymphocytic leukemia
The American Society of Hematology journal Blood Advances published an important...
Outcomes of COVID-19 in Patients with CLL: A Multicenter, International Experience
This is the full report from ASH Publications Blood Journam yesterday by Dr Mayo et al....
BTK inhibitors for the treatment of CLL - the current state of play of 'brutinibs'
In just a short time, in many places, BTK inhibitors (BTKi) have largely replaced...
Living in the USA with CLL and want to know where to sign up for your COVID-19 Vaccination? A State-by-State List
From MedPage Today: Every state has posted information on its plan; many (though not all) list...
COVID-19 management strategies and vaccine recommendations for patients with hematologic malignancies, USA NY Presbyterian perspective
This video replay is aimed at medical professionals, but seems easy to follow and has some specific...
Related Posts
- Autoimmune hemolytic anemia (AIHA), Immune thrombocytopenia (ITP) and other autoimmune complications and extranodal involvement in CLL
- Important SARS-CoV-2 and Covid-19 information for Chronic Lymphocytic Leukaemia/CLL patients
- Research shows blood cancer patients generate strong T cell immunity after SARS-CoV-2 vaccination
- Efficacy and safety of new‑generation BTKis (primarily acalabrutinib and zanubrutinib) in CLL/SLL: a systematic review and meta‑analysis
- Disease Flare During Temporary Interruption of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia ( CLL ) - Pseudo Richters
